TEMCAD 250MG CAPSULES

Temcad 250mg Capsules contain temozolomide, a prescription oral chemotherapy medicine widely used for the treatment of brain tumors, including glioblastoma multiforme and anaplastic astrocytoma. It works by damaging the DNA of cancer cells, effectively slowing their growth and preventing further multiplication. This potent oral anticancer therapy must be taken strictly under the supervision of a qualified oncologist.

Temcad 250 mg Capsule is prescribed as part of standard treatment protocols for primary and recurrent brain tumors. Targeting rapidly dividing tumor cells, it helps reduce tumor progression and improve patient outcomes. Careful monitoring by healthcare professionals ensures that the dosage is safe and effective for each patient.

As a trusted oral chemotherapy medicine, Temcad 250 mg Capsule offers the convenience of outpatient treatment while maintaining clinical effectiveness. This product is supplied for use in hospitals, oncology centers, and specialized treatment facilities and remains a reliable option for managing aggressive brain tumors under professional medical supervision.

Product Features

• Oral chemotherapy capsule
• Contains Temozolomide 250 mg
• Used in glioblastoma and brain tumor treatment
• Alkylating agent chemotherapy drug
• Convenient oral dosage form
• Suitable for hospital and outpatient oncology use
• Developed under strict pharmaceutical quality standards
• Prescription-required oncology medicine

How It Helps

• Damages DNA in cancer cells to prevent growth and multiplication
• Targets rapidly dividing tumor cells in glioblastoma and brain tumors
• Supports effective oral chemotherapy for hospital and outpatient use
• Helps improve treatment outcomes under an oncologist’s supervision